Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.5238
-0.0097 (-1.82%)
Dec 2, 2025, 12:53 PM EST
Elite Pharmaceuticals Employees
Elite Pharmaceuticals had 68 employees as of March 31, 2025. The number of employees increased by 4 or 6.25% compared to the previous year.
Employees
68
Change (1Y)
4
Growth (1Y)
6.25%
Revenue / Employee
$1,807,255
Profits / Employee
$204,757
Market Cap
573.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 68 | 4 | 6.25% |
| Mar 31, 2024 | 64 | 11 | 20.75% |
| Mar 31, 2023 | 53 | 10 | 23.26% |
| Mar 31, 2022 | 43 | 0 | - |
| Mar 31, 2021 | 43 | 0 | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Zomedica | 152 |
| Silence Therapeutics | 116 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
Elite Pharmaceuticals News
- 13 days ago - ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance - Nasdaq
- 14 days ago - Elite Pharmaceuticals Inc (ELTP) Q2 2026 Earnings Call Highlights: Surging Revenues and ... - GuruFocus
- 14 days ago - Q2 2026 Elite Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 14 days ago - Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information - Newsfile Corp
- 22 days ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 - Newsfile Corp
- 3 months ago - Elite Pharmaceuticals Inc (ELTP) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... - GuruFocus
- 3 months ago - Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M - Seeking Alpha